Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Doctors need to be better prepared to assess and treat obesity in patients.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.